(S)-2-(Boc-Amino)non-8-Enoic Acid CAS 300831-21-4 Kuchena >98.0% (GC) ee >99.0% Paritaprevir Intermediate Factory

Tsanangudzo Pfupi

Zita: (S)-2-(Boc-Amino)non-8-Enoic Acid

CAS: 300831-21-4

Kuchena: > 98.0% (GC)

iwo:> 99.0%

Chitarisiko: Brown Liquid

Pakati peParitaprevir (CAS: 1216941-48-8)

E-Mail: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-2-(Boc-Amino)non-8-Enoic Acid (CAS: 300831-21-4) with high quality, commercial production. Ruifu Chemical offers a wide range of chiral compounds. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name	(S)-2-(Boc-Amino)non-8-Enoic Acid
Mashoko anoreva zvakafanana	(S) -2-(tert-Butoxycarbonylamino)non-8-Enoic Acid;(S)-2-(Boc-Amino)-8-Nonenoic Acid;(2S) -2-[(2-Methylpropan-2-yl)oxycarbonylamino]non-8-Enoic Acid;(2S)-2-{[(tert-Butoxy)carbonyl]amino}non-8-Enoic Acid
Nhamba yeCAS	300831-21-4
Nhamba yeCAT	RF-CC347
Stock Status	Mudura
Molecular Formula	C14H25NO4
Molecular Weight	271.35
Density	1.035±0.06 g/cm3
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Brown Liquid
Kuchena / Analysis Method	>98.0% (GC)
ee	>99.0%
Test Standard	Enterprise Standard
Usage	Pakati peParitaprevir (CAS: 1216941-48-8)

Package & Kuchengeta:

Package: Fluorinated Bhodhoro, 25kg / Drum, kana zvinoenderana nezvinodiwa nemutengi

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

FAQ:

Application:

(S) -2- (Boc-Amino) non-8-Enoic Acid (CAS: 300831-21-4) inogona kushandiswa sepakati mukugadzirwa kweParitaprevir (CAS: 1216941-48-8) uye analogs ane hukama.Paritaprevir chizvarwa chechipiri NS3/4A protease inhibitor, chikamu chezvese-muromo, interferon-isina hepatitis C virus combination therapy yakagadzirwa neEnanta Pharmaceuticals neAbbVie.The fixed-dose tablet yeParitaprevir, Ombitasvir neRitonavir yakatorwa pamwe chete neDasabuvir yakatenderwa kurapwa kwechirwere cheHCV genotype 1 muUSA neEU muna 2014, uyezve yakabvumidzwa kurapwa kwegenotype 4 chronic HCV utachiona pasina cirrhosis neUS. FDA muna 2015.